Libtayo gained FDA approval as the first immunotherapy for high-risk cutaneous squamous cell carcinoma, promising improved outcomes post-surgery and radiation.

CHICAGO – Patients with colorectal cancer who had acneiform rash and applied LUT014 gel, an investigational topical BRAF inhibitor, were more likely to experience improvement of their rash compared ...

Researchers from the UCLA Health Jonsson Comprehensive Cancer Center and The University of Texas MD Anderson Cancer Center have demonstrated that a novel topical BRAF inhibitor gel called LUT014 ...

Please provide your email address to receive an email when new articles are posted on . ATR-04 has received a fast track designation from the FDA for epidermal growth factor receptor ...

The use of an investigational topical BRAF-inhibiting gel appeared to be effective in treating acneiform rash in patients with advanced colorectal cancer who were treated with an epidermal growth ...

Itchy skin (pruritus) without a rash may be caused by dry skin, allergies, bug bites, or an underlying medical condition. Health issues like liver disease, kidney disease, and thyroid disorders can ...

As summer tans fade, fall is the ideal time to check for signs of skin cancer. That’s because skin cancer doesn’t take a vacation.

People experiencing their first psychotic episode who also have skin conditions such as rashes or itching are at greater risk ...